Global Diabetes Drugs Market Report, History and Forecast 2016-2027, Breakdown Data by Manufacturers, Key Regions, Types and Application
SKU ID :QYR-18723560 | Published Date: 09-Jul-2021 | No. of pages: 145Description
TOC
1 Diabetes Drugs Market Overview
1.1 Diabetes Drugs Product Overview
1.2 Diabetes Drugs Market Segment by Type
1.2.1 Insulin
1.2.2 DPP-4
1.2.3 GLP-1
1.2.4 SGLT-2
1.3 Global Diabetes Drugs Market Size by Type
1.3.1 Global Diabetes Drugs Market Size Overview by Type (2016-2027)
1.3.2 Global Diabetes Drugs Historic Market Size Review by Type (2016-2021)
1.3.2.1 Global Diabetes Drugs Sales Breakdown in Volume by Type (2016-2021)
1.3.2.2 Global Diabetes Drugs Sales Breakdown in Value by Type (2016-2021)
1.3.2.3 Global Diabetes Drugs Average Selling Price (ASP) by Type (2016-2021)
1.3.3 Global Diabetes Drugs Forecasted Market Size by Type (2022-2027)
1.3.3.1 Global Diabetes Drugs Sales Breakdown in Volume by Type (2022-2027)
1.3.3.2 Global Diabetes Drugs Sales Breakdown in Value by Type (2022-2027)
1.3.3.3 Global Diabetes Drugs Average Selling Price (ASP) by Type (2022-2027)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Diabetes Drugs Sales Breakdown by Type (2016-2021)
1.4.2 Europe Diabetes Drugs Sales Breakdown by Type (2016-2021)
1.4.3 Asia-Pacific Diabetes Drugs Sales Breakdown by Type (2016-2021)
1.4.4 Latin America Diabetes Drugs Sales Breakdown by Type (2016-2021)
1.4.5 Middle East and Africa Diabetes Drugs Sales Breakdown by Type (2016-2021)
2 Global Diabetes Drugs Market Competition by Company
2.1 Global Top Players by Diabetes Drugs Sales (2016-2021)
2.2 Global Top Players by Diabetes Drugs Revenue (2016-2021)
2.3 Global Top Players Diabetes Drugs Price (2016-2021)
2.4 Global Top Manufacturers Diabetes Drugs Manufacturing Base Distribution, Sales Area, Product Type
2.5 Diabetes Drugs Market Competitive Situation and Trends
2.5.1 Diabetes Drugs Market Concentration Rate (2016-2021)
2.5.2 Global 5 and 10 Largest Manufacturers by Diabetes Drugs Sales and Revenue in 2020
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Diabetes Drugs as of 2020)
2.7 Date of Key Manufacturers Enter into Diabetes Drugs Market
2.8 Key Manufacturers Diabetes Drugs Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Diabetes Drugs Status and Outlook by Region
3.1 Global Diabetes Drugs Market Size and CAGR by Region: 2016 VS 2021 VS 2026
3.2 Global Diabetes Drugs Historic Market Size by Region
3.2.1 Global Diabetes Drugs Sales in Volume by Region (2016-2021)
3.2.2 Global Diabetes Drugs Sales in Value by Region (2016-2021)
3.2.3 Global Diabetes Drugs Sales (Volume & Value) Price and Gross Margin (2016-2021)
3.3 Global Diabetes Drugs Forecasted Market Size by Region
3.3.1 Global Diabetes Drugs Sales in Volume by Region (2022-2027)
3.3.2 Global Diabetes Drugs Sales in Value by Region (2022-2027)
3.3.3 Global Diabetes Drugs Sales (Volume & Value), Price and Gross Margin (2022-2027)
4 Global Diabetes Drugs by Application
4.1 Diabetes Drugs Market Segment by Application
4.1.1 Type 1 Diabetes
4.1.2 Type 2 Diabetes
4.2 Global Diabetes Drugs Market Size by Application
4.2.1 Global Diabetes Drugs Market Size Overview by Application (2016-2027)
4.2.2 Global Diabetes Drugs Historic Market Size Review by Application (2016-2021)
4.2.2.1 Global Diabetes Drugs Sales Breakdown in Volume, by Application (2016-2021)
4.2.2.2 Global Diabetes Drugs Sales Breakdown in Value, by Application (2016-2021)
4.2.2.3 Global Diabetes Drugs Average Selling Price (ASP) by Application (2016-2021)
4.2.3 Global Diabetes Drugs Forecasted Market Size by Application (2022-2027)
4.2.3.1 Global Diabetes Drugs Sales Breakdown in Volume, by Application (2022-2027)
4.2.3.2 Global Diabetes Drugs Sales Breakdown in Value, by Application (2022-2027)
4.2.3.3 Global Diabetes Drugs Average Selling Price (ASP) by Application (2022-2027)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Diabetes Drugs Sales Breakdown by Application (2016-2021)
4.3.2 Europe Diabetes Drugs Sales Breakdown by Application (2016-2021)
4.3.3 Asia-Pacific Diabetes Drugs Sales Breakdown by Application (2016-2021)
4.3.4 Latin America Diabetes Drugs Sales Breakdown by Application (2016-2021)
4.3.5 Middle East and Africa Diabetes Drugs Sales Breakdown by Application (2016-2021)
5 North America Diabetes Drugs by Country
5.1 North America Diabetes Drugs Historic Market Size by Country
5.1.1 North America Diabetes Drugs Sales in Volume by Country (2016-2021)
5.1.2 North America Diabetes Drugs Sales in Value by Country (2016-2021)
5.2 North America Diabetes Drugs Forecasted Market Size by Country
5.2.1 North America Diabetes Drugs Sales in Volume by Country (2022-2027)
5.2.2 North America Diabetes Drugs Sales in Value by Country (2022-2027)
6 Europe Diabetes Drugs by Country
6.1 Europe Diabetes Drugs Historic Market Size by Country
6.1.1 Europe Diabetes Drugs Sales in Volume by Country (2016-2021)
6.1.2 Europe Diabetes Drugs Sales in Value by Country (2016-2021)
6.2 Europe Diabetes Drugs Forecasted Market Size by Country
6.2.1 Europe Diabetes Drugs Sales in Volume by Country (2022-2027)
6.2.2 Europe Diabetes Drugs Sales in Value by Country (2022-2027)
7 Asia-Pacific Diabetes Drugs by Region
7.1 Asia-Pacific Diabetes Drugs Historic Market Size by Region
7.1.1 Asia-Pacific Diabetes Drugs Sales in Volume by Region (2016-2021)
7.1.2 Asia-Pacific Diabetes Drugs Sales in Value by Region (2016-2021)
7.2 Asia-Pacific Diabetes Drugs Forecasted Market Size by Region
7.2.1 Asia-Pacific Diabetes Drugs Sales in Volume by Region (2022-2027)
7.2.2 Asia-Pacific Diabetes Drugs Sales in Value by Region (2022-2027)
8 Latin America Diabetes Drugs by Country
8.1 Latin America Diabetes Drugs Historic Market Size by Country
8.1.1 Latin America Diabetes Drugs Sales in Volume by Country (2016-2021)
8.1.2 Latin America Diabetes Drugs Sales in Value by Country (2016-2021)
8.2 Latin America Diabetes Drugs Forecasted Market Size by Country
8.2.1 Latin America Diabetes Drugs Sales in Volume by Country (2022-2027)
8.2.2 Latin America Diabetes Drugs Sales in Value by Country (2022-2027)
9 Middle East and Africa Diabetes Drugs by Country
9.1 Middle East and Africa Diabetes Drugs Historic Market Size by Country
9.1.1 Middle East and Africa Diabetes Drugs Sales in Volume by Country (2016-2021)
9.1.2 Middle East and Africa Diabetes Drugs Sales in Value by Country (2016-2021)
9.2 Middle East and Africa Diabetes Drugs Forecasted Market Size by Country
9.2.1 Middle East and Africa Diabetes Drugs Sales in Volume by Country (2022-2027)
9.2.2 Middle East and Africa Diabetes Drugs Sales in Value by Country (2022-2027)
10 Company Profiles and Key Figures in Diabetes Drugs Business
10.1 Sanofi
10.1.1 Sanofi Corporation Information
10.1.2 Sanofi Introduction and Business Overview
10.1.3 Sanofi Diabetes Drugs Sales, Revenue and Gross Margin (2016-2021)
10.1.4 Sanofi Diabetes Drugs Products Offered
10.1.5 Sanofi Recent Development
10.2 AstraZeneca
10.2.1 AstraZeneca Corporation Information
10.2.2 AstraZeneca Introduction and Business Overview
10.2.3 AstraZeneca Diabetes Drugs Sales, Revenue and Gross Margin (2016-2021)
10.2.4 AstraZeneca Diabetes Drugs Products Offered
10.2.5 AstraZeneca Recent Development
10.3 Bayer
10.3.1 Bayer Corporation Information
10.3.2 Bayer Introduction and Business Overview
10.3.3 Bayer Diabetes Drugs Sales, Revenue and Gross Margin (2016-2021)
10.3.4 Bayer Diabetes Drugs Products Offered
10.3.5 Bayer Recent Development
10.4 Biocon
10.4.1 Biocon Corporation Information
10.4.2 Biocon Introduction and Business Overview
10.4.3 Biocon Diabetes Drugs Sales, Revenue and Gross Margin (2016-2021)
10.4.4 Biocon Diabetes Drugs Products Offered
10.4.5 Biocon Recent Development
10.5 Boehringer Ingelheim
10.5.1 Boehringer Ingelheim Corporation Information
10.5.2 Boehringer Ingelheim Introduction and Business Overview
10.5.3 Boehringer Ingelheim Diabetes Drugs Sales, Revenue and Gross Margin (2016-2021)
10.5.4 Boehringer Ingelheim Diabetes Drugs Products Offered
10.5.5 Boehringer Ingelheim Recent Development
10.6 Dongbao Pharmaceutical
10.6.1 Dongbao Pharmaceutical Corporation Information
10.6.2 Dongbao Pharmaceutical Introduction and Business Overview
10.6.3 Dongbao Pharmaceutical Diabetes Drugs Sales, Revenue and Gross Margin (2016-2021)
10.6.4 Dongbao Pharmaceutical Diabetes Drugs Products Offered
10.6.5 Dongbao Pharmaceutical Recent Development
10.7 Eli Lilly
10.7.1 Eli Lilly Corporation Information
10.7.2 Eli Lilly Introduction and Business Overview
10.7.3 Eli Lilly Diabetes Drugs Sales, Revenue and Gross Margin (2016-2021)
10.7.4 Eli Lilly Diabetes Drugs Products Offered
10.7.5 Eli Lilly Recent Development
10.8 Ganlee
10.8.1 Ganlee Corporation Information
10.8.2 Ganlee Introduction and Business Overview
10.8.3 Ganlee Diabetes Drugs Sales, Revenue and Gross Margin (2016-2021)
10.8.4 Ganlee Diabetes Drugs Products Offered
10.8.5 Ganlee Recent Development
10.9 Ginwa
10.9.1 Ginwa Corporation Information
10.9.2 Ginwa Introduction and Business Overview
10.9.3 Ginwa Diabetes Drugs Sales, Revenue and Gross Margin (2016-2021)
10.9.4 Ginwa Diabetes Drugs Products Offered
10.9.5 Ginwa Recent Development
10.10 Guangzhou Baiyun Mountain
10.10.1 Company Basic Information, Manufacturing Base and Competitors
10.10.2 Diabetes Drugs Product Category, Application and Specification
10.10.3 Guangzhou Baiyun Mountain Diabetes Drugs Sales, Revenue, Price and Gross Margin (2016-2021)
10.10.4 Main Business Overview
10.10.5 Guangzhou Baiyun Mountain Recent Development
10.11 Hisun Pharmacy
10.11.1 Hisun Pharmacy Corporation Information
10.11.2 Hisun Pharmacy Introduction and Business Overview
10.11.3 Hisun Pharmacy Diabetes Drugs Sales, Revenue and Gross Margin (2016-2021)
10.11.4 Hisun Pharmacy Diabetes Drugs Products Offered
10.11.5 Hisun Pharmacy Recent Development
10.12 Hua Dong
10.12.1 Hua Dong Corporation Information
10.12.2 Hua Dong Introduction and Business Overview
10.12.3 Hua Dong Diabetes Drugs Sales, Revenue and Gross Margin (2016-2021)
10.12.4 Hua Dong Diabetes Drugs Products Offered
10.12.5 Hua Dong Recent Development
10.13 Huadong Medicine
10.13.1 Huadong Medicine Corporation Information
10.13.2 Huadong Medicine Introduction and Business Overview
10.13.3 Huadong Medicine Diabetes Drugs Sales, Revenue and Gross Margin (2016-2021)
10.13.4 Huadong Medicine Diabetes Drugs Products Offered
10.13.5 Huadong Medicine Recent Development
10.14 Jumpcan Pharmacy
10.14.1 Jumpcan Pharmacy Corporation Information
10.14.2 Jumpcan Pharmacy Introduction and Business Overview
10.14.3 Jumpcan Pharmacy Diabetes Drugs Sales, Revenue and Gross Margin (2016-2021)
10.14.4 Jumpcan Pharmacy Diabetes Drugs Products Offered
10.14.5 Jumpcan Pharmacy Recent Development
10.15 KELUN
10.15.1 KELUN Corporation Information
10.15.2 KELUN Introduction and Business Overview
10.15.3 KELUN Diabetes Drugs Sales, Revenue and Gross Margin (2016-2021)
10.15.4 KELUN Diabetes Drugs Products Offered
10.15.5 KELUN Recent Development
10.16 Merck & Co.
10.16.1 Merck & Co. Corporation Information
10.16.2 Merck & Co. Introduction and Business Overview
10.16.3 Merck & Co. Diabetes Drugs Sales, Revenue and Gross Margin (2016-2021)
10.16.4 Merck & Co. Diabetes Drugs Products Offered
10.16.5 Merck & Co. Recent Development
10.17 MSD
10.17.1 MSD Corporation Information
10.17.2 MSD Introduction and Business Overview
10.17.3 MSD Diabetes Drugs Sales, Revenue and Gross Margin (2016-2021)
10.17.4 MSD Diabetes Drugs Products Offered
10.17.5 MSD Recent Development
10.18 North China Pharmaceutical Group Corporation
10.18.1 North China Pharmaceutical Group Corporation Corporation Information
10.18.2 North China Pharmaceutical Group Corporation Introduction and Business Overview
10.18.3 North China Pharmaceutical Group Corporation Diabetes Drugs Sales, Revenue and Gross Margin (2016-2021)
10.18.4 North China Pharmaceutical Group Corporation Diabetes Drugs Products Offered
10.18.5 North China Pharmaceutical Group Corporation Recent Development
10.19 Novartis
10.19.1 Novartis Corporation Information
10.19.2 Novartis Introduction and Business Overview
10.19.3 Novartis Diabetes Drugs Sales, Revenue and Gross Margin (2016-2021)
10.19.4 Novartis Diabetes Drugs Products Offered
10.19.5 Novartis Recent Development
10.20 Novo Nordisk
10.20.1 Novo Nordisk Corporation Information
10.20.2 Novo Nordisk Introduction and Business Overview
10.20.3 Novo Nordisk Diabetes Drugs Sales, Revenue and Gross Margin (2016-2021)
10.20.4 Novo Nordisk Diabetes Drugs Products Offered
10.20.5 Novo Nordisk Recent Development
10.21 Sanofi
10.21.1 Sanofi Corporation Information
10.21.2 Sanofi Introduction and Business Overview
10.21.3 Sanofi Diabetes Drugs Sales, Revenue and Gross Margin (2016-2021)
10.21.4 Sanofi Diabetes Drugs Products Offered
10.21.5 Sanofi Recent Development
10.22 SHIJIAZHUANG YILING PHARMACEUTICAL
10.22.1 SHIJIAZHUANG YILING PHARMACEUTICAL Corporation Information
10.22.2 SHIJIAZHUANG YILING PHARMACEUTICAL Introduction and Business Overview
10.22.3 SHIJIAZHUANG YILING PHARMACEUTICAL Diabetes Drugs Sales, Revenue and Gross Margin (2016-2021)
10.22.4 SHIJIAZHUANG YILING PHARMACEUTICAL Diabetes Drugs Products Offered
10.22.5 SHIJIAZHUANG YILING PHARMACEUTICAL Recent Development
10.23 Takeda
10.23.1 Takeda Corporation Information
10.23.2 Takeda Introduction and Business Overview
10.23.3 Takeda Diabetes Drugs Sales, Revenue and Gross Margin (2016-2021)
10.23.4 Takeda Diabetes Drugs Products Offered
10.23.5 Takeda Recent Development
10.24 Taloph
10.24.1 Taloph Corporation Information
10.24.2 Taloph Introduction and Business Overview
10.24.3 Taloph Diabetes Drugs Sales, Revenue and Gross Margin (2016-2021)
10.24.4 Taloph Diabetes Drugs Products Offered
10.24.5 Taloph Recent Development
10.25 Tianan Pharmaceutical
10.25.1 Tianan Pharmaceutical Corporation Information
10.25.2 Tianan Pharmaceutical Introduction and Business Overview
10.25.3 Tianan Pharmaceutical Diabetes Drugs Sales, Revenue and Gross Margin (2016-2021)
10.25.4 Tianan Pharmaceutical Diabetes Drugs Products Offered
10.25.5 Tianan Pharmaceutical Recent Development
10.26 Tonghua DongBao
10.26.1 Tonghua DongBao Corporation Information
10.26.2 Tonghua DongBao Introduction and Business Overview
10.26.3 Tonghua DongBao Diabetes Drugs Sales, Revenue and Gross Margin (2016-2021)
10.26.4 Tonghua DongBao Diabetes Drugs Products Offered
10.26.5 Tonghua DongBao Recent Development
10.27 Wanbang Biopharmaceuticals
10.27.1 Wanbang Biopharmaceuticals Corporation Information
10.27.2 Wanbang Biopharmaceuticals Introduction and Business Overview
10.27.3 Wanbang Biopharmaceuticals Diabetes Drugs Sales, Revenue and Gross Margin (2016-2021)
10.27.4 Wanbang Biopharmaceuticals Diabetes Drugs Products Offered
10.27.5 Wanbang Biopharmaceuticals Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Diabetes Drugs Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Diabetes Drugs Industrial Chain Analysis
11.4 Diabetes Drugs Market Dynamics
11.4.1 Industry Trends
11.4.2 Market Drivers
11.4.3 Market Challenges
11.4.4 Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Diabetes Drugs Distributors
12.3 Diabetes Drugs Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
Tables & Figures
List of Tables
Table 1. Major Company of Insulin
Table 2. Major Company of DPP-4
Table 3. Major Company of GLP-1
Table 4. Major Company of SGLT-2
Table 5. Global Diabetes Drugs Sales by Type 2016 VS 2021 VS 2027 (US$ Million)
Table 6. Global Diabetes Drugs Sales by Type (2016-2021) & (M Units)
Table 7. Global Diabetes Drugs Sales Market Share in Volume by Type (2016-2021)
Table 8. Global Diabetes Drugs Sales by Type (2016-2021) & (US& Million)
Table 9. Global Diabetes Drugs Market Share in Value by Type (2016-2021)
Table 10. Global Diabetes Drugs Price by Type (2016-2021) & (USD/Unit)
Table 11. Global Diabetes Drugs Sales by Type (2022-2027) & (M Units)
Table 12. Global Diabetes Drugs Sales Market Share in Volume by Type (2022-2027)
Table 13. Global Diabetes Drugs Sales by Type (2022-2027) & (US$ Million)
Table 14. Global Diabetes Drugs Sales Market Share in Value by Type (2022-2027)
Table 15. Global Diabetes Drugs Price by Type (2022-2027) & (USD/Unit)
Table 16. North America Diabetes Drugs Sales by Type (2016-2021) & (M Units)
Table 17. North America Diabetes Drugs Sales by Type (2016-2021) & (US$ Million)
Table 18. Europe Diabetes Drugs Sales (M Units) by Type (2016-2021)
Table 19. Europe Diabetes Drugs Sales by Type (2016-2021) & (US$ Million)
Table 20. Asia-Pacific Diabetes Drugs Sales (M Units) by Type (2016-2021)
Table 21. Asia-Pacific Diabetes Drugs Sales by Type (2016-2021) & (US$ Million)
Table 22. Latin America Diabetes Drugs Sales (M Units) by Type (2016-2021)
Table 23. Latin America Diabetes Drugs Sales by Type (2016-2021) & (US$ Million)
Table 24. Middle East and Africa Diabetes Drugs Sales (M Units) by Type (2016-2021)
Table 25. Middle East and Africa Diabetes Drugs Sales by Type (2016-2021) & (US$ Million)
Table 26. Global Diabetes Drugs Sales by Company (2016-2021) & (M Units)
Table 27. Global Diabetes Drugs Sales Share by Company (2016-2021)
Table 28. Global Diabetes Drugs Revenue by Company (2016-2021) & (US$ Million)
Table 29. Global Diabetes Drugs Revenue Share by Company (2016-2021)
Table 30. Global Market Diabetes Drugs Price by Company (2016-2021) & (USD/Unit)
Table 31. Global Diabetes Drugs Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 32. Global Diabetes Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 33. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Diabetes Drugs as of 2020
Table 34. Date of Key Manufacturers Enter into Diabetes Drugs Market
Table 35. Key Manufacturers Diabetes Drugs Product Type
Table 36. Mergers & Acquisitions, Expansion Plans
Table 37. Global Diabetes Drugs Market Size Comparison by Region (US$ Million): 2016 VS 2021 VS 2027
Table 38. Global Diabetes Drugs Sales by Region (2016-2021) & (M Units)
Table 39. Global Diabetes Drugs Sales Market Share in Volume by Region (2016-2021)
Table 40. Global Diabetes Drugs Sales by Region (2016-2021) & (US$ Million)
Table 41. Global Diabetes Drugs Sales Market Share in Value by Region (2016-2021)
Table 42. Global Diabetes Drugs Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 43. Global Diabetes Drugs Sales by Region (2022-2027) & (M Units)
Table 44. Global Diabetes Drugs Sales Market Share in Volume by Region (2022-2027)
Table 45. Global Diabetes Drugs Sales by Region (2022-2027) & (US$ Million)
Table 46. Global Diabetes Drugs Sales Market Share in Value by Region (2022-2027)
Table 47. Global Diabetes Drugs Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2022-2027)
Table 48. Global Diabetes Drugs Sales by Application: 2016 VS 2021 VS 2027 (US$ Million)
Table 49. Global Diabetes Drugs Sales by Application (2016-2021) & (M Units)
Table 50. Global Diabetes Drugs Sales Market Share in Volume by Application (2016-2021)
Table 51. Global Diabetes Drugs Sales by Application (2016-2021) & (US$ Million)
Table 52. Global Diabetes Drugs Sales Market Share in Value by Application (2016-2021)
Table 53. Global Diabetes Drugs Price by Application (2016-2021) & (USD/Unit)
Table 54. Global Diabetes Drugs Sales by Application (2022-2027) & (M Units)
Table 55. Global Diabetes Drugs Sales Market Share in Volume by Application (2022-2027)
Table 56. Global Diabetes Drugs Sales by Application (2022-2027) & (US$ Million)
Table 57. Global Diabetes Drugs Sales Market Share in Value by Application (2022-2027)
Table 58. Global Diabetes Drugs Price by Application (2022-2027) & (USD/Unit)
Table 59. North America Diabetes Drugs Sales by Application (2016-2021) (M Units)
Table 60. North America Diabetes Drugs Sales by Application (2016-2021) & (US$ Million)
Table 61. North America Diabetes Drugs Sales Market Share in Value by Application in 2020
Table 62. Europe Diabetes Drugs Sales by Application (2016-2021) (M Units)
Table 63. Europe Diabetes Drugs Sales by Application (2016-2021) & (US$ Million)
Table 64. Europe Diabetes Drugs Sales Market Share in Value by Application in 2020
Table 65. Asia-Pacific Diabetes Drugs Sales by Application (2016-2021) (M Units)
Table 66. Asia-Pacific Diabetes Drugs Sales by Application (2016-2021) & (US$ Million)
Table 67. Asia-Pacific Diabetes Drugs Sales Market Share in Value by Application in 2020
Table 68. Latin America Diabetes Drugs Sales by Application (2016-2021) (M Units)
Table 69. Latin America Diabetes Drugs Sales by Application (2016-2021) & (US$ Million)
Table 70. Latin America Diabetes Drugs Sales Market Share in Value by Application in 2020
Table 71. Middle East and Africa Diabetes Drugs Sales by Application (2016-2021) (M Units)
Table 72. Middle East and Africa Diabetes Drugs Sales by Application (2016-2021) & (US$ Million)
Table 73. Middle East and Africa Diabetes Drugs Sales Market Share in Value by Application in 2020
Table 74. North America Diabetes Drugs Sales by Country (2016-2021) & (M Units)
Table 75. North America Diabetes Drugs Sales Market Share in Volume by Country (2016-2021)
Table 76. North America Diabetes Drugs Sales by Country (2016-2021) & (US$ Million)
Table 77. North America Diabetes Drugs Sales Market Share in Value by Country (2016-2021)
Table 78. North America Diabetes Drugs Sales by Country (2022-2027) & (M Units)
Table 79. North America Diabetes Drugs Sales Market Share in Volume by Country (2022-2027)
Table 80. North America Diabetes Drugs Sales by Country (2022-2027) & (US$ Million)
Table 81. North America Diabetes Drugs Sales Market Share in Value by Country (2022-2027)
Table 82. Europe Diabetes Drugs Sales by Country (2016-2021) & (M Units)
Table 83. Europe Diabetes Drugs Sales Market Share in Volume by Country (2016-2021)
Table 84. Europe Diabetes Drugs Sales by Country (2016-2021) & (US$ Million)
Table 85. Europe Diabetes Drugs Sales Market Share in Value by Country (2016-2021)
Table 86. Europe Diabetes Drugs Sales by Country (2022-2027) & (M Units)
Table 87. Europe Diabetes Drugs Sales Market Share in Volume by Country (2022-2027)
Table 88. Europe Diabetes Drugs Sales by Country (2022-2027) & (US$ Million)
Table 89. Europe Diabetes Drugs Sales Market Share in Value by Country (2022-2027)
Table 90. Asia-Pacific Diabetes Drugs Sales by Region (2016-2021) & (M Units)
Table 91. Asia-Pacific Diabetes Drugs Sales Market Share in Volume by Region (2016-2021)
Table 92. Asia-Pacific Diabetes Drugs Sales by Region (2016-2021) & (US$ Million)
Table 93. Asia-Pacific Diabetes Drugs Sales Market Share in Value by Region (2016-2021)
Table 94. Asia-Pacific Diabetes Drugs Sales by Region (2022-2027) & (M Units)
Table 95. Asia-Pacific Diabetes Drugs Sales Market Share in Volume by Region (2022-2027)
Table 96. Asia-Pacific Diabetes Drugs Sales by Region (2022-2027) & (US$ Million)
Table 97. Asia-Pacific Diabetes Drugs Sales Market Share in Value by Region (2022-2027)
Table 98. Latin America Diabetes Drugs Sales by Country (2016-2021) & (M Units)
Table 99. Latin America Diabetes Drugs Sales Market Share in Volume by Country (2016-2021)
Table 100. Latin America Diabetes Drugs Sales by Country (2016-2021) & (US$ Million)
Table 101. Latin America Diabetes Drugs Sales Market Share in Value by Country (2016-2021)
Table 102. Latin America Diabetes Drugs Sales by Country (2022-2027) & (M Units)
Table 103. Latin America Diabetes Drugs Sales Market Share in Volume by Country (2022-2027)
Table 104. Latin America Diabetes Drugs Sales by Country (2022-2027) & (US$ Million)
Table 105. Latin America Diabetes Drugs Sales Market Share in Value by Country (2022-2027)
Table 106. Middle East and Africa Diabetes Drugs Sales by Country (2016-2021) & (M Units)
Table 107. Middle East and Africa Diabetes Drugs Sales Market Share in Volume by Country (2016-2021)
Table 108. Middle East and Africa Diabetes Drugs Sales by Country (2016-2021) & (US$ Million)
Table 109. Middle East and Africa Diabetes Drugs Sales Market Share in Value by Country (2016-2021)
Table 110. Middle East and Africa Diabetes Drugs Sales by Country (2022-2027) & (M Units)
Table 111. Middle East and Africa Diabetes Drugs Sales Market Share in Volume by Country (2022-2027)
Table 112. Middle East and Africa Diabetes Drugs Sales by Country (2022-2027) & (US$ Million)
Table 113. Middle East and Africa Diabetes Drugs Sales Market Share in Value by Country (2022-2027)
Table 114. Sanofi Corporation Information
Table 115. Sanofi Introduction and Business Overview
Table 116. Sanofi Diabetes Drugs Sales (M Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 117. Sanofi Diabetes Drugs Product
Table 118. Sanofi Recent Development
Table 119. AstraZeneca Corporation Information
Table 120. AstraZeneca Introduction and Business Overview
Table 121. AstraZeneca Diabetes Drugs Sales (M Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 122. AstraZeneca Diabetes Drugs Product
Table 123. AstraZeneca Recent Development
Table 124. Bayer Corporation Information
Table 125. Bayer Introduction and Business Overview
Table 126. Bayer Diabetes Drugs Sales (M Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 127. Bayer Diabetes Drugs Product
Table 128. Bayer Recent Development
Table 129. Biocon Corporation Information
Table 130. Biocon Introduction and Business Overview
Table 131. Biocon Diabetes Drugs Sales (M Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 132. Biocon Diabetes Drugs Product
Table 133. Biocon Recent Development
Table 134. Boehringer Ingelheim Corporation Information
Table 135. Boehringer Ingelheim Introduction and Business Overview
Table 136. Boehringer Ingelheim Diabetes Drugs Sales (M Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 137. Boehringer Ingelheim Diabetes Drugs Product
Table 138. Boehringer Ingelheim Recent Development
Table 139. Dongbao Pharmaceutical Corporation Information
Table 140. Dongbao Pharmaceutical Introduction and Business Overview
Table 141. Dongbao Pharmaceutical Diabetes Drugs Sales (M Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 142. Dongbao Pharmaceutical Diabetes Drugs Product
Table 143. Dongbao Pharmaceutical Recent Development
Table 144. Eli Lilly Corporation Information
Table 145. Eli Lilly Introduction and Business Overview
Table 146. Eli Lilly Diabetes Drugs Sales (M Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 147. Eli Lilly Diabetes Drugs Product
Table 148. Eli Lilly Recent Development
Table 149. Ganlee Corporation Information
Table 150. Ganlee Introduction and Business Overview
Table 151. Ganlee Diabetes Drugs Sales (M Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 152. Ganlee Diabetes Drugs Product
Table 153. Ganlee Recent Development
Table 154. Ginwa Corporation Information
Table 155. Ginwa Introduction and Business Overview
Table 156. Ginwa Diabetes Drugs Sales (M Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 157. Ginwa Diabetes Drugs Product
Table 158. Ginwa Recent Development
Table 159. Guangzhou Baiyun Mountain Corporation Information
Table 160. Guangzhou Baiyun Mountain Introduction and Business Overview
Table 161. Guangzhou Baiyun Mountain Diabetes Drugs Sales (M Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 162. Guangzhou Baiyun Mountain Diabetes Drugs Product
Table 163. Guangzhou Baiyun Mountain Recent Development
Table 164. Hisun Pharmacy Corporation Information
Table 165. Hisun Pharmacy Introduction and Business Overview
Table 166. Hisun Pharmacy Diabetes Drugs Sales (M Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 167. Hisun Pharmacy Diabetes Drugs Product
Table 168. Hisun Pharmacy Recent Development
Table 169. Hua Dong Corporation Information
Table 170. Hua Dong Introduction and Business Overview
Table 171. Hua Dong Diabetes Drugs Sales (M Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 172. Hua Dong Diabetes Drugs Product
Table 173. Hua Dong Recent Development
Table 174. Huadong Medicine Corporation Information
Table 175. Huadong Medicine Introduction and Business Overview
Table 176. Huadong Medicine Diabetes Drugs Sales (M Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 177. Huadong Medicine Diabetes Drugs Product
Table 178. Huadong Medicine Recent Development
Table 179. Jumpcan Pharmacy Corporation Information
Table 180. Jumpcan Pharmacy Introduction and Business Overview
Table 181. Jumpcan Pharmacy Diabetes Drugs Sales (M Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 182. Jumpcan Pharmacy Diabetes Drugs Product
Table 183. Jumpcan Pharmacy Recent Development
Table 184. KELUN Corporation Information
Table 185. KELUN Introduction and Business Overview
Table 186. KELUN Diabetes Drugs Sales (M Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 187. KELUN Diabetes Drugs Product
Table 188. KELUN Recent Development
Table 189. Merck & Co. Corporation Information
Table 190. Merck & Co. Introduction and Business Overview
Table 191. Merck & Co. Diabetes Drugs Sales (M Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 192. Merck & Co. Diabetes Drugs Product
Table 193. Merck & Co. Recent Development
Table 194. MSD Corporation Information
Table 195. MSD Introduction and Business Overview
Table 196. MSD Diabetes Drugs Sales (M Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 197. MSD Diabetes Drugs Product
Table 198. MSD Recent Development
Table 199. North China Pharmaceutical Group Corporation Corporation Information
Table 200. North China Pharmaceutical Group Corporation Introduction and Business Overview
Table 201. North China Pharmaceutical Group Corporation Diabetes Drugs Sales (M Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 202. North China Pharmaceutical Group Corporation Diabetes Drugs Product
Table 203. North China Pharmaceutical Group Corporation Recent Development
Table 204. Novartis Corporation Information
Table 205. Novartis Introduction and Business Overview
Table 206. Novartis Diabetes Drugs Sales (M Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 207. Novartis Diabetes Drugs Product
Table 208. Novartis Recent Development
Table 209. Novo Nordisk Corporation Information
Table 210. Novo Nordisk Introduction and Business Overview
Table 211. Novo Nordisk Diabetes Drugs Sales (M Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 212. Novo Nordisk Diabetes Drugs Product
Table 213. Novo Nordisk Recent Development
Table 214. Sanofi Corporation Information
Table 215. Sanofi Introduction and Business Overview
Table 216. Sanofi Diabetes Drugs Sales (M Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 217. Sanofi Diabetes Drugs Product
Table 218. Sanofi Recent Development
Table 219. SHIJIAZHUANG YILING PHARMACEUTICAL Corporation Information
Table 220. SHIJIAZHUANG YILING PHARMACEUTICAL Introduction and Business Overview
Table 221. SHIJIAZHUANG YILING PHARMACEUTICAL Diabetes Drugs Sales (M Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 222. SHIJIAZHUANG YILING PHARMACEUTICAL Diabetes Drugs Product
Table 223. SHIJIAZHUANG YILING PHARMACEUTICAL Recent Development
Table 224. Takeda Corporation Information
Table 225. Takeda Introduction and Business Overview
Table 226. Takeda Diabetes Drugs Sales (M Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 227. Takeda Diabetes Drugs Product
Table 228. Takeda Recent Development
Table 229. Taloph Corporation Information
Table 230. Taloph Introduction and Business Overview
Table 231. Taloph Diabetes Drugs Sales (M Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 232. Taloph Diabetes Drugs Product
Table 233. Taloph Recent Development
Table 234. Tianan Pharmaceutical Introduction and Business Overview
Table 235. Tianan Pharmaceutical Diabetes Drugs Sales (M Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 236. Tianan Pharmaceutical Diabetes Drugs Product
Table 237. Tianan Pharmaceutical Recent Development
Table 238. Tianan Pharmaceutical Corporation Information
Table 239. Tonghua DongBao Corporation Information
Table 240. Tonghua DongBao Introduction and Business Overview
Table 241. Tonghua DongBao Diabetes Drugs Sales (M Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 242. Tonghua DongBao Diabetes Drugs Product
Table 243. Tonghua DongBao Recent Development
Table 244. Wanbang Biopharmaceuticals Corporation Information
Table 245. Wanbang Biopharmaceuticals Introduction and Business Overview
Table 246. Wanbang Biopharmaceuticals Diabetes Drugs Sales (M Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 247. Wanbang Biopharmaceuticals Diabetes Drugs Product
Table 248. Wanbang Biopharmaceuticals Recent Development
Table 249. Key Raw Materials Lists
Table 250. Raw Materials Key Suppliers Lists
Table 251. Diabetes Drugs Market Trends
Table 252. Diabetes Drugs Market Drivers
Table 253. Diabetes Drugs Market Challenges
Table 254. Diabetes Drugs Market Restraints
Table 255. Diabetes Drugs Distributors List
Table 256. Diabetes Drugs Downstream Customers
Table 257. Research Programs/Design for This Report
Table 258. Key Data Information from Secondary Sources
Table 259. Key Data Information from Primary Sources
List of Figures
Figure 1. Diabetes Drugs Product Picture
Figure 2. Global Diabetes Drugs Market Size, 2016 VS 2021 VS 2027 (US$ Million)
Figure 3. Global Diabetes Drugs Market Size Status and Outlook (2016-2027) & (US$ Million)
Figure 4. Global Diabetes Drugs Sales Status and Outlook (2016-2027) & (M Units)
Figure 5. Product Picture of Insulin
Figure 6. Global Insulin Sales YoY Growth (2016-2021) & (M Units)
Figure 7. Product Picture of DPP-4
Figure 8. Global DPP-4 Sales YoY Growth (2016-2021) & (M Units)
Figure 9. Product Picture of GLP-1
Figure 10. Global GLP-1 Sales YoY Growth (2016-2021) & (M Units)
Figure 11. Product Picture of SGLT-2
Figure 12. Global SGLT-2 Sales YoY Growth (2016-2021) & (M Units)
Figure 13. Global Diabetes Drugs Sales by Type (2016-2027) & (US$ Million)
Figure 14. Global Diabetes Drugs Sales Market Share in Volume by Type (2016-2021)
Figure 15. Global Diabetes Drugs Sales Market Share in Value by Type (2016-2021)
Figure 16. Global Diabetes Drugs Sales Market Share in Volume by Type (2022-2027)
Figure 17. Global Diabetes Drugs Sales Market Share in Value by Type (2022-2027)
Figure 18. North America Diabetes Drugs Sales Market Share in Volume by Type in 2020
Figure 19. North America Diabetes Drugs Sales Market Share in Value by Type in 2020
Figure 20. Europe Diabetes Drugs Sales Market Share in Volume by Type in 2020
Figure 21. Europe Diabetes Drugs Sales Market Share in Value by Type in 2020
Figure 22. Asia-Pacific Diabetes Drugs Sales Market Share in Volume by Type in 2020
Figure 23. Asia-Pacific Diabetes Drugs Sales Market Share in Value by Type in 2020
Figure 24. Latin America Diabetes Drugs Sales Market Share in Volume by Type in 2020
Figure 25. Latin America Diabetes Drugs Sales Market Share in Value by Type in 2020
Figure 26. Middle East and Africa Diabetes Drugs Sales Market Share in Volume by Type in 2020
Figure 27. Middle East and Africa Diabetes Drugs Sales Market Share in Value by Type in 2020
Figure 28. The 5 and 10 Largest Manufacturers in the World: Market Share by Diabetes Drugs Sales in 2020
Figure 29. The 5 and 10 Largest Manufacturers in the World: Market Share by Diabetes Drugs Revenue in 2020
Figure 30. Diabetes Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2016 VS 2020
Figure 31. Product Picture of Type 1 Diabetes
Figure 32. Global Type 1 Diabetes Sales YoY Growth (2016-2027) & (M Units)
Figure 33. Product Picture of Type 2 Diabetes
Figure 34. Global Type 2 Diabetes Sales YoY Growth (2016-2027) & (M Units)
Figure 35. Global Diabetes Drugs Sales by Application (2016-2027) & (US$ Million)
Figure 36. Global Diabetes Drugs Sales Market Share in Volume by Application (2016-2021)
Figure 37. Global Diabetes Drugs Sales Market Share in Value by Application (2016-2021)
Figure 38. Global Diabetes Drugs Sales Market Share in Volume by Application (2022-2027)
Figure 39. North America Diabetes Drugs Sales Market Share in Volume by Application in 2020
Figure 40. Latin America Diabetes Drugs Sales Market Share in Value by Application in 2020
Figure 41. Middle East and Africa Diabetes Drugs Sales Market Share in Value by Application in 2020
Figure 42. Key Raw Materials Price
Figure 43. Diabetes Drugs Manufacturing Cost Structure
Figure 44. Diabetes Drugs Industrial Chain Analysis
Figure 45. Channels of Distribution
Figure 46. Distributors Profiles
Figure 47. Bottom-up and Top-down Approaches for This Report
Figure 48. Data Triangulation
Figure 49. Key Executives Interviewed
Companies
Sanofi
AstraZeneca
Bayer
Biocon
Boehringer Ingelheim
Dongbao Pharmaceutical
Eli Lilly
Ganlee
Ginwa
Guangzhou Baiyun Mountain
Hisun Pharmacy
Hua Dong
Huadong Medicine
Jumpcan Pharmacy
KELUN
Merck & Co.
MSD
North China Pharmaceutical Group Corporation
Novartis
Novo Nordisk
Sanofi
SHIJIAZHUANG YILING PHARMACEUTICAL
Takeda
Taloph
Tianan Pharmaceutical
Tonghua DongBao
Wanbang Biopharmaceuticals
- PRICE
-
$3350$6700$5025Buy Now